Anke Niedernberg
Corporate Officer/Principal presso ADVANZ PHARMA CORP. LIMITED
Profilo
Anke Niedernberg is currently the Chief Transformation Officer at Advanz Pharma Corp.
Ltd.
She was previously a Partner at HgCapital Beratungs GmbH & Co. KG from 2008 to 2010.
Posizioni attive di Anke Niedernberg
| Società | Posizione | Inizio |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01/10/2021 |
Precedenti posizioni note di Anke Niedernberg
| Società | Posizione | Fine |
|---|---|---|
| HgCapital Beratungs GmbH & Co. KG | Investitore di Private Equity | 01/01/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| HgCapital Beratungs GmbH & Co. KG | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Anke Niedernberg
